![Anthony Polverino](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anthony Polverino
Director/Board Member at
BRAINSTORM CELL THERAPEUTICS INC.
Net worth: 23 157 $ as of 2026-07-30
Profile
Dr. Anthony J.
Polverino is an Independent Director at Brainstorm Cell Therapeutics, Inc. He is on the Board of Directors at Brainstorm Cell Therapeutics, Inc. Dr. Polverino was previously employed as a Chief Scientific Officer & EVP-Early Development by Zymeworks BC, Inc., a Chief Scientific Officer by Kite Pharma, Inc., an Executive Director-Therapeutic Innovation Unit by Amgen, Inc., and a Chief Scientific Officer & EVP-Early Development by Zymeworks, Inc. He received his undergraduate degree from the University of Adelaide and a doctorate degree from Flinders University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-02-25 | 25,730 ( 0.23% ) | 23 157 $ | 2026-07-30 |
Anthony Polverino active positions
| Companies | Position | Start |
|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Director/Board Member | 2018-02-04 |
Former positions of Anthony Polverino
| Companies | Position | End |
|---|---|---|
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Develops protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases | Chief Tech/Sci/R&D Officer | 2022-01-18 |
| KITE PHARMA INC | Chief Tech/Sci/R&D Officer | 2017-12-31 |
| ZYMEWORKS INC. | Chief Tech/Sci/R&D Officer | - |
| AMGEN INC. | Corporate Officer/Principal | - |
Training of Anthony Polverino
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
65
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Brainstorm Cell Therapeutics, Inc.
 Brainstorm Cell Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company, which develops innovative adult stem cell therapeutic products | Health Technology |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Develops protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases | Health Technology |
University of Adelaide
 University of Adelaide Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Flinders University
 Flinders University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kite Pharma, Inc.
 Kite Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which engages in the development of novel cancer immunotherapeutic products | Health Technology |
Zymeworks, Inc.
 Zymeworks, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
- Stock Market
- Insiders
- Anthony Polverino
